Clinical trials
Carcinoma, Transitional Cell trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
79 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2015 | 5 |
| 2016 | 6 |
| 2017 | 8 |
| 2018 | 7 |
| 2019 | 10 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 9 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 6 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
| Recruiting | 16 |
| Active, not recruiting | 15 |
| Terminated | 13 |
| Withdrawn | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Spanish Oncology Genito-Urinary Group | 5 |
| Bristol-Myers Squibb | 4 |
| Eli Lilly and Company | 4 |
| Hoffmann-La Roche | 4 |
| Merck Sharp & Dohme LLC | 4 |
| Pfizer | 4 |
| Incyte Corporation | 3 |
| UroGen Pharma Ltd. | 3 |
| Associació per a la Recerca Oncologica, Spain | 2 |
| Astellas Pharma Global Development, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 79 |
| Urinary Bladder Neoplasms | 32 |
| Carcinoma, Non-Small-Cell Lung | 19 |
| Carcinoma, Renal Cell | 15 |
| Neoplasm Metastasis | 15 |
| Melanoma | 14 |
| Colorectal Neoplasms | 11 |
| Carcinoma, Hepatocellular | 10 |
| Neoplasms | 10 |
| Squamous Cell Carcinoma of Head and Neck | 9 |
Trials
Showing 76 to 79 of 79. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.